Literature DB >> 35143263

Narratives Are Useful Strategies for Overcoming Challenges in Risk Communication.

Rachel D Altshuler1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35143263      PMCID： PMC8842221          DOI： 10.2105/AJPH.2021.306669

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   11.561


× No keyword cloud information.
  6 in total

1.  Trust and shared decision-making: an emerging research agenda.

Authors:  Vikki Entwistle
Journal:  Health Expect       Date:  2004-12       Impact factor: 3.377

Review 2.  Narrative communication in cancer prevention and control: a framework to guide research and application.

Authors:  Matthew W Kreuter; Melanie C Green; Joseph N Cappella; Michael D Slater; Meg E Wise; Doug Storey; Eddie M Clark; Daniel J O'Keefe; Deborah O Erwin; Kathleen Holmes; Leslie J Hinyard; Thomas Houston; Sabra Woolley
Journal:  Ann Behav Med       Date:  2007-06

Review 3.  Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.

Authors:  Joyce H Kim; Patrick M Dougherty; Salahadin Abdi
Journal:  Gynecol Oncol       Date:  2015-01-10       Impact factor: 5.482

Review 4.  On the Usefulness of Narratives: An Interdisciplinary Review and Theoretical Model.

Authors:  Victoria A Shaffer; Elizabeth S Focella; Andrew Hathaway; Laura D Scherer; Brian J Zikmund-Fisher
Journal:  Ann Behav Med       Date:  2018-04-19

Review 5.  Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status.

Authors:  E A G Joosten; L DeFuentes-Merillas; G H de Weert; T Sensky; C P F van der Staak; C A J de Jong
Journal:  Psychother Psychosom       Date:  2008-04-16       Impact factor: 17.659

6.  US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life.

Authors:  Andrea C Enzinger; Kaushik Ghosh; Nancy L Keating; David M Cutler; Mary Beth Landrum; Alexi A Wright
Journal:  J Clin Oncol       Date:  2021-07-22       Impact factor: 50.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.